Centre for Commercialization of Regenerative Medicine
Registration:
6
of
7
(2024-03-04
to
2024-05-17)
Grant, Contribution or Other Financial Benefit
- Seeking funding from the Strategic Innovation Fund to allow the client to expand regenerative cell and gene therapy manufacturing in Ontario.